RT @TumorBoardTues
4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc
⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇
#bonumce #OncTwitter #gyncsm #gynonc
RT @TumorBoardTues
3/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
🟠Earn 🆓 #CME 🏆
🟠#CME ℹ️🔗http://bit.ly/3YRDkog
📸 Faculty disclosures & important CME info 👇
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme
RT @TumorBoardTues
4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc
⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇
#bonumce #OncTwitter #gyncsm #gynonc
RT @TumorBoardTues
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme #posttest
RT @TumorBoardTues
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog
🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w pembro + lenvatinib combo therapy
🟢Which other tox may occur if these GI toxicities are not effectively managed?
#OncTwitter #gyncsm #gynonc #cme #PreTest
RT @TumorBoardTues
5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
#CME 🔗http://bit.ly/3YRDkog
🟢#PreTest Q 4️⃣
📊During treatment w pembro + lenva, pt develops grade 3 HTN
🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme #PreTest
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme #posttest
Very nice RT @TumorBoardTuesday: 4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc
⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇
#gynonc #gyncsm #onctwitter #bonumce
4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc
⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇
#bonumce #OncTwitter #gyncsm #gynonc
3/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
🟠Earn 🆓 #CME 🏆
🟠#CME ℹ️🔗http://bit.ly/3YRDkog
📸 Faculty disclosures & important CME info 👇
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme
5...4...3...2...1...it's the final countdown
⏰30m warning
🔥#EndometrialCancer #webinar w @DrMMurphy & @drteplinsky🔥
👩🏫B4 we begin...👩🏻🏫
✅Answer #PreTest polls 👇
🔁Retweet & tag colleagues
#TumorBoardTuesday #OncTwitter #MedTwitter #GynCSM #gynonc
---
RT @TumorBoardTues
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog
🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w…
https://twitter.com/TumorBoardTues/status/1616204008028528643
#endometrialcancer #webinar #PreTest #TumorBoardTuesday #OncTwitter #medtwitter #gyncsm #gynonc #cme
5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
#CME 🔗http://bit.ly/3YRDkog
🟢#PreTest Q 4️⃣
📊During treatment w pembro + lenva, pt develops grade 3 HTN
🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #cme #PreTest
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog
🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w pembro + lenvatinib combo therapy
🟢Which other tox may occur if these GI toxicities are not effectively managed?
#OncTwitter #gyncsm #gynonc #cme #PreTest
RT @TumorBoardTues
2/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer #MedTweetorial
🆓 CME > full info➕ref list🗒️& program archive
👉http://bit.ly/3VBGJEJ
🔑#CME info👇
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #medtweetorial #cme
RT @TumorBoardTues
3/#TumorBoardTuesday #BonumCE #OncTwitter #GynOnc #gyncsm #EndometrialCancer
🟢Which I/O +🎯tx combo is FDA approved for treatment of advanced or metastatic #EndometrialCarcinoma?
nivo = nivolumab
dostarlimab = dostarlimab-gxly
pembro = pembrolizumab
#bonumce #OncTwitter #gynonc #gyncsm #endometrialcancer #endometrialcarcinoma
RT @TumorBoardTues
4/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer
If you picked pembro + lenva…
You’re right🎉
Pembro (PD-1🎯mAb) + lenva (multi-🎯TKI)
➡️🏁accelerated approval adv EC in 2019
Ph3 confirmatory trial✅➡️#KEYNOTE-775
➡️full FDA approval 2021
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #keynote
RT @TumorBoardTues
5/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#EndometrialCancer most common gyn cancer in🇺🇸
Rates 📈
Est in 2022…
📊New cases: 69,950
📊Deaths: 12,550
Most pts dx early stage - gd prognosis✅
Approx 9% dx met disease➡️5y survival <20%➡️plat chemo SOC 1st line tx
#OncTwitter #gyncsm #gynonc #endometrialcancer
RT @TumorBoardTues
6/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc
After progression on chemotx, tx for metastatic #EndometrialCancer is influenced by tumor molecular subtype
🧬Cancer Genome Atlas ID’d 4️⃣ mol subclasses…
1️⃣POLE ultramutated
2️⃣dMMR/MSI-H
3️⃣Copy # low
4️⃣Copy # high
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer
RT @TumorBoardTues
7/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc
🧬Faulty DNA repair (dMMR/MSI-H)➡️high tumor mutation burden
➡️more tumor neoantigens
➡️sensitivity to ICI
💎Two FDA approved ICIs in dMMR/MSI-H #EndometrialCancer:
🔹Pembro (PD-1 mAb)
🔹Dostarlimab (PD-1 mAb)
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer
RT @TumorBoardTues
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
Pivotal trials leading to FDA approval in 2L met MSI-H/dMMR #EndometrialCarcinoma
🔸Pembro: #KEYNOTE158 (phase 2)
🔹Dostarlimab: #GARNET (phase 1)
🔑Efficacy & safety data 📷👇
#bonumce #OncTwitter #gyncsm #gynonc #endometrialcancer #endometrialcarcinoma #keynote158 #garnet